In the Pharma industry, data integrity is essential for effective decision-making, regulatory compliance, and business operations. Chryselys’ Data Anomaly Detection capability provides a robust framework to identify, analyze, and correct anomalies across both master and transactional datasets. By integrating AI-driven anomaly detection with statistical methodologies, we help Pharma companies eliminate data inconsistencies, reduce compliance risks, and enhance overall data quality.
Pharmaceutical organizations manage vast amounts of data from multiple sources, including internal CRM, MDM platforms, third-party vendors, and real-world evidence (RWE). Data fragmentation, duplicate records, and inconsistent file formats create challenges in maintaining data accuracy and completeness.
Anomalies in sales data, rebate claims, and patient records can lead to incorrect forecasting, revenue leakage, and compliance violations. Failing to identify and correct these anomalies can result in financial penalties and reputational damage.
Combines traditional statistical methods and AI-driven models for precise anomaly detection. Reduces false positives while ensuring critical data discrepancies are flagged.
Detects anomalies in HCP/HCO records, patient claims, sales transactions, and payer data. Ensures holistic data validation across all critical datasets.
Works with enterprise MDM platforms, CRM, and third-party data sources. Supports integration with Snowflake, AWS, and other cloud data warehouses.
Uses AI-powered contextual insights to provide explanations for anomalies. Helps non-technical users understand why an issue occurred.
Allows business teams to review flagged anomalies before making data corrections.
Uses feedback loops to refine anomaly detection models over time. Adapts to new data trends and evolving business needs.

Ensure a single source of truth for master data

Prevent false spikes or dips in sales data that could distort performance metrics

Improve forecasting accuracy by ensuring clean input data

Detect sales anomalies that could impact revenue forecasting

Identify rebate claim discrepancies to prevent revenue losses
Validate incoming vendor data before integrating it into enterprise systems Data anomalies can distort business insights, leading to flawed strategies and compliance risks. Chryselys’ AI-Powered Data Anomaly Detection ensures data accuracy, improves operational efficiency, and enhances decision-making across the pharmaceutical value chain.
With automated detection, real-time alerts, and deep root-cause analysis, our solutions minimize risks and maximize data integrity, making every business decision more reliable.
Revolutionize your business trajectory and achieve unprecedented growth with our committed partnership